Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Apr;72(1):55–59.

Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus.

S Lobatto 1, M R Daha 1, F C Breedveld 1, E K Pauwels 1, J H Evers-Schouten 1, A A Voetman 1, A Cats 1, L A Van Es 1
PMCID: PMC1541487  PMID: 3396221

Abstract

In the present study, we tested mononuclear phagocyte system function in nine healthy controls and 15 SLE patients with complement activating 123I-labelled aggregates of human IgG (AIgG). Clearance half-time of AIgG was 26 +/- 8 min in controls, compared to 58 +/- 27 min in patients (P less than 0.005). Binding of AIgG to erythrocytes was significantly lower in patients, 9.3 +/- 8.1 vs 24 +/- 20% (P less than 0.05). The increase of C3a-levels in plasma was significantly lower in patients than in controls (P less than 0.05 at 3 and 8 min), suggesting less complement activation. Liver and spleen uptake of 123I-AIgG was measured with a gamma camera and expressed as liver/spleen uptake ratios. In patients, the liver/spleen uptake ratios were significantly higher than in controls at 15 min, 3.8 +/- 2.0 vs 2.31 +/- 0.7 (P less than 0.05), due to less splenic uptake of AIgG. Correlations between clearance half-time or liver/spleen uptake ratios and immune complex levels or disease activity were not found. This study indicates that clearance of soluble AIgG is abnormal in patients with SLE, due to decreased splenic uptake of AIgG.

Full text

PDF
56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belmont H. M., Hopkins P., Edelson H. S., Kaplan H. B., Ludewig R., Weissmann G., Abramson S. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum. 1986 Sep;29(9):1085–1089. doi: 10.1002/art.1780290905. [DOI] [PubMed] [Google Scholar]
  2. Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxman F. J. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983 Feb;71(2):236–247. doi: 10.1172/JCI110764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Daha M. R., van Es L. A. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages. Immunology. 1982 Sep;47(1):203–209. [PMC free article] [PubMed] [Google Scholar]
  4. Frank M. M., Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med. 1979 Mar 8;300(10):518–523. doi: 10.1056/NEJM197903083001002. [DOI] [PubMed] [Google Scholar]
  5. Frank M. M., Lawley T. J., Hamburger M. I., Brown E. J. NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med. 1983 Feb;98(2):206–218. doi: 10.7326/0003-4819-98-2-218. [DOI] [PubMed] [Google Scholar]
  6. Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H., Frank M. M. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. Arthritis Rheum. 1982 Jan;25(1):48–54. doi: 10.1002/art.1780250108. [DOI] [PubMed] [Google Scholar]
  7. Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 May 1;155(5):1427–1438. doi: 10.1084/jem.155.5.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kauffmann R. H., Van Es L. A., Daha M. R. Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. J Immunol Methods. 1979;31(1-2):11–22. doi: 10.1016/0022-1759(79)90281-3. [DOI] [PubMed] [Google Scholar]
  9. Kimberly R. P., Parris T. M., Inman R. D., McDougal J. S. Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes. Clin Exp Immunol. 1983 Feb;51(2):261–268. [PMC free article] [PubMed] [Google Scholar]
  10. Kimberly R. P., Ralph P. Endocytosis by the mononuclear phagocyte system and autoimmune disease. Am J Med. 1983 Mar;74(3):481–493. doi: 10.1016/0002-9343(83)90986-5. [DOI] [PubMed] [Google Scholar]
  11. Lobatto S., Daha M. R., Voetman A. A., Evers-Schouten J. H., Van Es A. A., Pauwels E. K., Van Es L. A. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol. 1987 Jul;69(1):133–141. [PMC free article] [PubMed] [Google Scholar]
  12. Mannik M., Arend W. P. Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med. 1971 Sep 1;134(3 Pt 2):19s–31s. [PubMed] [Google Scholar]
  13. Parris T. M., Kimberly R. P., Inman R. D., McDougal J. S., Gibofsky A., Christian C. L. Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann Intern Med. 1982 Oct;97(4):526–532. doi: 10.7326/0003-4819-97-4-526. [DOI] [PubMed] [Google Scholar]
  14. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  15. Valentijn R. M., van Overhagen H., Hazevoet H. M., Hermans J., Cats A., Daha M. R., van ES L. A. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 1985 Aug;28(8):904–913. doi: 10.1002/art.1780280810. [DOI] [PubMed] [Google Scholar]
  16. Veerhuis R., Krol M. C., van Es L. A., Daha M. R. Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo. Clin Immunol Immunopathol. 1986 Dec;41(3):379–391. doi: 10.1016/0090-1229(86)90008-5. [DOI] [PubMed] [Google Scholar]
  17. Walport M. J., Ross G. D., Mackworth-Young C., Watson J. V., Hogg N., Lachmann P. J. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol. 1985 Mar;59(3):547–554. [PMC free article] [PubMed] [Google Scholar]
  18. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]
  19. van der Woude F. J., Beekhuis H., Beelen J. M., The T. H. Kinetic analysis of the blood clearance and organ uptake curves of IgG-coated red cells in HLA-typed controls and patients with Wegener's granulomatosis. Eur J Nucl Med. 1986;12(3):130–136. doi: 10.1007/BF00276705. [DOI] [PubMed] [Google Scholar]
  20. van der Woude F. J., van der Giessen M., Kallenberg C. G., Ouwehand W., Beekhuis H., Beelen J. M., van Son W. J., Hoedemaeker P. J., van der Hem G. K., The T. H. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin Exp Immunol. 1984 Mar;55(3):473–480. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES